We highlight four recent technological advances that will enhance the pharmaceutical industry’s ability to deliver value for patients. These examples are revolutionary technologies, from artificial intelligence solutions to supply chain lubricants.
GB SCIENCES' PLANT DISCOVERY PLATFORM
A drug discovery company called GB Sciences has built an AI platform that analyses the healing properties of plants from nine traditional medicine practices. The company has collaborated with ethnobotanists and data scientists to identify compounds in plants that have traditionally been used as treatments.
CHIEF.AI'S PAY-AS-YOU-GO PLATFORM
Machine learning platform, Chief.AI, in partnership with the Medicines Discovery Catapult, has launched a first-of-its-kind, no-code, pay-as-you-go artificial intelligence platform for drug discovery. The project will give small and medium-sized enterprises (SMEs) cloud-based access to AI models and data for drug discovery, clinical trials, and diagnostics.
CLARIVATE'S CORTELLIS SUPPLY CHAIN NETWORK™
Clarivate PLC is launching its digital partnering solution, Cortellis Supply Chain Network. The network will support more than 70,000 generics companies, API manufacturers, fine chemical manufacturers, excipient manufacturers, raw materials suppliers, and biopharmas, in their pursuit to maintain a steady supply chain.
CASTOR'S ONBOARDING TOOL
Castor is a decentralised clinical trial developer that has recently added a novel patient onboarding tool to its portfolio. The platform can recruit enrolees, pre-screen potential participants to ensure they meet the necessary criteria, and gather enrolee consent for digital or in-person participation.